Takushi Manabe

Takamatsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Long-term effects of L-carnitine on hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis: a multicenter retrospective study.

Long-term effects of L-carnitine on hyperammonemia and hepatic encephalopathy in patients with liver cirrhosis: a multicenter retrospective study.

Journal: European journal of gastroenterology & hepatology

Published: January 05, 2026

Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact.

Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 23, 2025

Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and Its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.

Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and Its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.

Journal: Internal medicine (Tokyo, Japan)

Published: March 16, 2025

Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Journal: Journal of gastroenterology

Published: November 04, 2024

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma.

Efficacy of olanzapine as an antiemetic drug for transcatheter arterial chemoembolization for hepatocellular carcinoma.

Journal: Scientific reports

Published: May 10, 2024

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients.

Journal: BMC gastroenterology

Published: January 27, 2024

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.

Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis.

Journal: Scientific reports

Published: September 11, 2023

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.

Journal: Cancers

Published: May 15, 2023

Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease.

Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease.

Journal: Diagnostics (Basel, Switzerland)

Published: February 19, 2023

Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy.

Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy.

Journal: Cancers

Published: February 16, 2023

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir.

Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir.

Journal: Internal medicine (Tokyo, Japan)

Published: November 30, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026